Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer IRVINE, CA – January XX, 2026 (GlobeNewswire) ...

A research team from the Department of Surgery and the Department of Medicine, School of Clinical Medicine, LKS Faculty of ...

Researchers will test whether the company's Genomic Prostate Score assay predicts disease progression and outcomes in a prospective cohort.

Prostate cancer is one of the most common cancers in men but often goes unnoticed. Experts stress early screening, awareness ...

An NHS patient waited over 400 days to start investigations for suspected prostate cancer. Another Scot waited 352 days with ...

A study from HKUMed demonstrates that prostate-specific antigen (PSA) screening can significantly reduce the incidence of ...

SAN FRANCISCO, December 09, 2025--(BUSINESS WIRE)--Artera, a developer of multimodal AI-based prognostic and predictive cancer tests, today announced the commercial launch of the ArteraAI Prostate ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

A new clinic is opening in Carberry, MB later this month that will focus on men's health, more specifically to diagnose ...

Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85%) are aged over 60. Subscribe to our newsletter for the latest sci-tech ...

The UK National Screening Committee has opened a 12-week public consultation on whether and how prostate cancer screening ...

Prostate cancer is highly treatable when detected early, as it carries a favourable prognosis. Therefore, awareness among ...